Cargando…

Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors

The mechanisms underlying pathophysiological regulation of tissue macrophage (Mφ) subsets remain poorly understood. From the expression of 207 Mφ genes comprising 31 markers for 10 subsets, 45 transcription factors (TFs), 56 immunometabolism enzymes, 23 trained immunity (innate immune memory) enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Bin, Wang, Jiwei, Fagenson, Alexander, Sun, Yu, Saredy, Jason, Lu, Yifan, Nanayakkara, Gayani, Yang, William Y., Yu, Daohai, Shao, Ying, Drummer, Charles, Johnson, Candice, Saaoud, Fatma, Zhang, Ruijing, Yang, Qian, Xu, Keman, Mastascusa, Kevin, Cueto, Ramon, Fu, Hangfei, Wu, Susu, Sun, Lizhe, Zhu, Peiqian, Qin, Xuebin, Yu, Jun, Fan, Daping, Shen, Ying H., Sun, Jianxin, Rogers, Thomas, Choi, Eric T., Wang, Hong, Yang, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880770/
https://www.ncbi.nlm.nih.gov/pubmed/31824480
http://dx.doi.org/10.3389/fimmu.2019.02612
_version_ 1783473826736111616
author Lai, Bin
Wang, Jiwei
Fagenson, Alexander
Sun, Yu
Saredy, Jason
Lu, Yifan
Nanayakkara, Gayani
Yang, William Y.
Yu, Daohai
Shao, Ying
Drummer, Charles
Johnson, Candice
Saaoud, Fatma
Zhang, Ruijing
Yang, Qian
Xu, Keman
Mastascusa, Kevin
Cueto, Ramon
Fu, Hangfei
Wu, Susu
Sun, Lizhe
Zhu, Peiqian
Qin, Xuebin
Yu, Jun
Fan, Daping
Shen, Ying H.
Sun, Jianxin
Rogers, Thomas
Choi, Eric T.
Wang, Hong
Yang, Xiaofeng
author_facet Lai, Bin
Wang, Jiwei
Fagenson, Alexander
Sun, Yu
Saredy, Jason
Lu, Yifan
Nanayakkara, Gayani
Yang, William Y.
Yu, Daohai
Shao, Ying
Drummer, Charles
Johnson, Candice
Saaoud, Fatma
Zhang, Ruijing
Yang, Qian
Xu, Keman
Mastascusa, Kevin
Cueto, Ramon
Fu, Hangfei
Wu, Susu
Sun, Lizhe
Zhu, Peiqian
Qin, Xuebin
Yu, Jun
Fan, Daping
Shen, Ying H.
Sun, Jianxin
Rogers, Thomas
Choi, Eric T.
Wang, Hong
Yang, Xiaofeng
author_sort Lai, Bin
collection PubMed
description The mechanisms underlying pathophysiological regulation of tissue macrophage (Mφ) subsets remain poorly understood. From the expression of 207 Mφ genes comprising 31 markers for 10 subsets, 45 transcription factors (TFs), 56 immunometabolism enzymes, 23 trained immunity (innate immune memory) enzymes, and 52 other genes in microarray data, we made the following findings. (1) When 34 inflammation diseases and tumor types were grouped into eight categories, there was differential expression of the 31 Mφ markers and 45 Mφ TFs, highlighted by 12 shared and 20 group-specific disease pathways. (2) Mφ in lung, liver, spleen, and intestine (LLSI-Mφ) express higher M1 Mφ markers than lean adipose tissue Mφ (ATMφ) physiologically. (3) Pro-adipogenic TFs C/EBPα and PPARγ and proinflammatory adipokine leptin upregulate the expression of M1 Mφ markers. (4) Among 10 immune checkpoint receptors (ICRs), LLSI-Mφ and bone marrow (BM) Mφ express higher levels of CD274 (PDL-1) than ATMφ, presumably to counteract the M1 dominant status via its reverse signaling behavior. (5) Among 24 intercellular communication exosome mediators, LLSI- and BM- Mφ prefer to use RAB27A and STX3 than RAB31 and YKT6, suggesting new inflammatory exosome mediators for propagating inflammation. (6) Mφ in peritoneal tissue and LLSI-Mφ upregulate higher levels of immunometabolism enzymes than does ATMφ. (7) Mφ from peritoneum and LLSI-Mφ upregulate more trained immunity enzyme genes than does ATMφ. Our results suggest that multiple new mechanisms including the cell surface, intracellular immunometabolism, trained immunity, and TFs may be responsible for disease group-specific and shared pathways. Our findings have provided novel insights on the pathophysiological regulation of tissue Mφ, the disease group-specific and shared pathways of Mφ, and novel therapeutic targets for cancers and inflammations.
format Online
Article
Text
id pubmed-6880770
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68807702019-12-10 Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors Lai, Bin Wang, Jiwei Fagenson, Alexander Sun, Yu Saredy, Jason Lu, Yifan Nanayakkara, Gayani Yang, William Y. Yu, Daohai Shao, Ying Drummer, Charles Johnson, Candice Saaoud, Fatma Zhang, Ruijing Yang, Qian Xu, Keman Mastascusa, Kevin Cueto, Ramon Fu, Hangfei Wu, Susu Sun, Lizhe Zhu, Peiqian Qin, Xuebin Yu, Jun Fan, Daping Shen, Ying H. Sun, Jianxin Rogers, Thomas Choi, Eric T. Wang, Hong Yang, Xiaofeng Front Immunol Immunology The mechanisms underlying pathophysiological regulation of tissue macrophage (Mφ) subsets remain poorly understood. From the expression of 207 Mφ genes comprising 31 markers for 10 subsets, 45 transcription factors (TFs), 56 immunometabolism enzymes, 23 trained immunity (innate immune memory) enzymes, and 52 other genes in microarray data, we made the following findings. (1) When 34 inflammation diseases and tumor types were grouped into eight categories, there was differential expression of the 31 Mφ markers and 45 Mφ TFs, highlighted by 12 shared and 20 group-specific disease pathways. (2) Mφ in lung, liver, spleen, and intestine (LLSI-Mφ) express higher M1 Mφ markers than lean adipose tissue Mφ (ATMφ) physiologically. (3) Pro-adipogenic TFs C/EBPα and PPARγ and proinflammatory adipokine leptin upregulate the expression of M1 Mφ markers. (4) Among 10 immune checkpoint receptors (ICRs), LLSI-Mφ and bone marrow (BM) Mφ express higher levels of CD274 (PDL-1) than ATMφ, presumably to counteract the M1 dominant status via its reverse signaling behavior. (5) Among 24 intercellular communication exosome mediators, LLSI- and BM- Mφ prefer to use RAB27A and STX3 than RAB31 and YKT6, suggesting new inflammatory exosome mediators for propagating inflammation. (6) Mφ in peritoneal tissue and LLSI-Mφ upregulate higher levels of immunometabolism enzymes than does ATMφ. (7) Mφ from peritoneum and LLSI-Mφ upregulate more trained immunity enzyme genes than does ATMφ. Our results suggest that multiple new mechanisms including the cell surface, intracellular immunometabolism, trained immunity, and TFs may be responsible for disease group-specific and shared pathways. Our findings have provided novel insights on the pathophysiological regulation of tissue Mφ, the disease group-specific and shared pathways of Mφ, and novel therapeutic targets for cancers and inflammations. Frontiers Media S.A. 2019-11-14 /pmc/articles/PMC6880770/ /pubmed/31824480 http://dx.doi.org/10.3389/fimmu.2019.02612 Text en Copyright © 2019 Lai, Wang, Fagenson, Sun, Saredy, Lu, Nanayakkara, Yang, Yu, Shao, Drummer, Johnson, Saaoud, Zhang, Yang, Xu, Mastascusa, Cueto, Fu, Wu, Sun, Zhu, Qin, Yu, Fan, Shen, Sun, Rogers, Choi, Wang and Yang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lai, Bin
Wang, Jiwei
Fagenson, Alexander
Sun, Yu
Saredy, Jason
Lu, Yifan
Nanayakkara, Gayani
Yang, William Y.
Yu, Daohai
Shao, Ying
Drummer, Charles
Johnson, Candice
Saaoud, Fatma
Zhang, Ruijing
Yang, Qian
Xu, Keman
Mastascusa, Kevin
Cueto, Ramon
Fu, Hangfei
Wu, Susu
Sun, Lizhe
Zhu, Peiqian
Qin, Xuebin
Yu, Jun
Fan, Daping
Shen, Ying H.
Sun, Jianxin
Rogers, Thomas
Choi, Eric T.
Wang, Hong
Yang, Xiaofeng
Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors
title Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors
title_full Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors
title_fullStr Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors
title_full_unstemmed Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors
title_short Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors
title_sort twenty novel disease group-specific and 12 new shared macrophage pathways in eight groups of 34 diseases including 24 inflammatory organ diseases and 10 types of tumors
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880770/
https://www.ncbi.nlm.nih.gov/pubmed/31824480
http://dx.doi.org/10.3389/fimmu.2019.02612
work_keys_str_mv AT laibin twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT wangjiwei twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT fagensonalexander twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT sunyu twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT saredyjason twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT luyifan twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT nanayakkaragayani twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT yangwilliamy twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT yudaohai twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT shaoying twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT drummercharles twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT johnsoncandice twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT saaoudfatma twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT zhangruijing twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT yangqian twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT xukeman twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT mastascusakevin twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT cuetoramon twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT fuhangfei twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT wususu twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT sunlizhe twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT zhupeiqian twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT qinxuebin twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT yujun twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT fandaping twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT shenyingh twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT sunjianxin twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT rogersthomas twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT choierict twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT wanghong twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors
AT yangxiaofeng twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors